QQ客服 官方微博 反馈留言

	Downregulation of long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression
	Wu, Jingjing; Chen, Hongfeng; Meng, Tian; Sheng, Jiayu; Zhang, Yuzhu; Wang, Bing; Ye, Meina; Chen, Hao
刊名	BIOMEDICINE & PHARMACOTHERAPY
	2019
卷号	115
关键词	HCP5 Cisplatin resistance Triple-Negative breast cancer PTEN
ISSN号	0753-3322
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3631789
专题	上海中医药大学
推荐引用方式 GB/T 7714	Wu, Jingjing,Chen, Hongfeng,Meng, Tian,et al. Downregulation of long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression[J]. BIOMEDICINE & PHARMACOTHERAPY,2019,115.
APA	Wu, Jingjing.,Chen, Hongfeng.,Meng, Tian.,Sheng, Jiayu.,Zhang, Yuzhu.,...&Chen, Hao.(2019).Downregulation of long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression.BIOMEDICINE & PHARMACOTHERAPY,115.
MLA	Wu, Jingjing,et al."Downregulation of long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression".BIOMEDICINE & PHARMACOTHERAPY 115(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。